Subject characteristics | Overall survival (OS) | Cancer-specific survival (CSS) | ||
---|---|---|---|---|
HR (95%CI) | P-value | HR (95%CI) | P-value | |
Year of diagnosis | ||||
2000–2001 | Reference | |||
2002–2005 | 0.85 (0.37 ~ 1.99) | 0.713 | ||
2006–2017 | 0.44 (0.2 ~ 0.98) | 0.044 | ||
Laterality | ||||
Bilateral | Reference | Reference | ||
Left | 0.81 (0.45 ~ 1.45) | 0.475 | 0.89(0.43 ~ 1.82) | 0.746 |
Paired site, but no information concerning laterality | 0.74 (0.27 ~ 2.03) | 0.554 | 1.02 (0.31 ~ 3.32) | 0.972 |
Right | 0.53 (0.27 ~ 1.05) | 0.068 | 0.75 (0.33 ~ 1.68) | 0.481 |
Surgery status | ||||
No surgery | Reference | Reference | ||
Surgery | 0.18 (0.07 ~ 0.41) | < 0.001 | 0.27 (0.1 ~ 0.75) | 0.011 |
Number of primary tumors | ||||
1st of 2 or more primaries | Reference | Reference | ||
One primary only | 2 (1.01 ~ 3.97) | 0.046 | 2.99 (1.11 ~ 8.02) | 0.03 |
Race | ||||
Black | Reference | Reference | ||
Other (American Indian/AK Native, Asian/Pacific Islander) | 0.35 (0.13 ~ 0.97) | 0.043 | 0.58 (0.18 ~ 1.87) | 0.362 |
White | 0.4 (0.19 ~ 0.83) | 0.014 | 0.43 (0.18 ~ 1.01) | 0.053 |
Marital status at diagnosis | ||||
DSW | Reference | Reference | ||
Married | 0.6 (0.34 ~ 1.05) | 0.072 | 0.81 (0.38 ~ 1.71) | 0.582 |
Single | 0.83 (0.41 ~ 1.64) | 0.585 | 1.14 (0.47 ~ 2.75) | 0.77 |
Unknown | 0.34 (0.08 ~ 1.46) | 0.145 | 0.39 (0.05 ~ 2.79) | 0.349 |
Median household income | ||||
< 50,000 | Reference | Reference | ||
>=70,000 | 1.01 (0.45 ~ 2.23) | 0.987 | 0.69 (0.27 ~ 1.77) | 0.44 |
50,000-69,999 | 0.96 (0.44 ~ 2.08) | 0.916 | 1.02 (0.41 ~ 2.54) | 0.968 |
Age | ||||
<=57 | Reference | Reference | ||
>=74 | 1.57 (0.79 ~ 3.11) | 0.197 | 0.96 (0.38 ~ 2.41) | 0.924 |
58–73 | 0.88 (0.49 ~ 1.58) | 0.667 | 1.15 (0.57 ~ 2.34) | 0.696 |
Grade | ||||
I/II | Reference | Reference | ||
III/IV | 2.14 (1.21 ~ 3.78) | 0.009 | 3.08 (1.45 ~ 6.54) | 0.004 |
Unknown | 2.1 (1.03 ~ 4.31) | 0.042 | 3.48 (1.47 ~ 8.29) | 0.005 |
Seer stage | ||||
Distant | Reference | Reference | ||
Localized | 2.19 (0.51 ~ 9.37) | 0.292 | 1.67 (0.23 ~ 12.41) | 0.615 |
Regional | 1.19 (0.42 ~ 3.43) | 0.741 | 1.17 (0.34 ~ 4.11) | 0.801 |
Unknown | 0.97 (0.21 ~ 4.42) | 0.973 | 1.01 (0.16 ~ 6.39) | 0.994 |
Stage | ||||
I | Reference | Reference | ||
II | 6.8 (1.89 ~ 24.44) | 0.003 | 7.89 (1.32 ~ 47.2) | 0.024 |
III | 6.35 (1.51 ~ 26.8) | 0.012 | 5.93 (0.85 ~ 41.28) | 0.072 |
IV | 6.49 (1.39 ~ 30.39) | 0.018 | 7.49 (0.96 ~ 58.33) | 0.055 |
Unknown | 13.76 (3.65 ~ 51.85) | < 0.001 | 12.25 (1.74 ~ 86) | 0.012 |
tumor size | ||||
<=59 | Reference | Reference | ||
>=177 | 2.48 (0.98 ~ 6.28) | 0.055 | 3.07 (0.87 ~ 10.76) | 0.08 |
60–176 | 1.28 (0.58 ~ 2.81) | 0.543 | 1.36 (0.47 ~ 3.98) | 0.57 |
Unknown | 1.23 (0.53 ~ 2.9) | 0.63 | 1.03 (0.32 ~ 3.28) | 0.964 |
CA125 | ||||
negative | Reference | Reference | ||
positive | 1.55 (0.65 ~ 3.69) | 0.319 | 2.45 (0.84 ~ 7.21) | 0.102 |
Unknown | 1.93 (1.03 ~ 3.6) | 0.04 | 2.08 (0.89 ~ 4.9) | 0.093 |